Examine the execution behind the strategy.
Drovix is an institutional liquidity provider with its own market-making and bridge technology. Evaluate the pricing, execution and connectivity arrangement against the measures that matter to your fund.
Execution evaluation / Fund notebook
A result needs
a reference.
Use a measurement lens to reveal the records and assumptions behind an execution assessment.
Observation / Price
Define the reference before judging the fill.
- Question
- Which reference, at which time, for which size?
- Records to examine
- Instrument, side, size, reference source, reference timestamp and execution record.
- Interpretation
- A price comparison means little without a consistent benchmark. Market conditions and order size remain part of the result; this is not a promise of a particular spread or outcome.
Drovix’s market-making and execution arrangement should be evaluated against the fund’s chosen benchmark, with the reference methodology made explicit.
Explore market-makingThe investment thesis, the proprietary signal and the decision to trade. Drovix’s contribution is the institutional liquidity and execution relationship, backed by its own market-making and bridge technology.
Continue the review
References for your evaluation
These public references explain the framework. Confirm the terms and technical scope applicable to your arrangement with the desk.
Talk to the institutional desk
Make the evaluation specific.
Discuss the instruments, execution records and measurement boundaries your desk needs to evaluate Drovix.
Contact DrovixLeveraged OTC products, including Forex and CFDs, carry a high level of risk and a counterparty may lose more than its initial margin. The Drovix offering is directed exclusively at Eligible Counterparties and Professional Clients; Drovix does not provide services to retail clients. Content on this page is factual and descriptive only and does not constitute investment advice, a recommendation, or an offer or solicitation to transact.
Drovix acts as principal in bilateral OTC transactions with approved institutional counterparties. It is not a public exchange, MTF, OTF or ECN. Services are not offered to retail clients or in jurisdictions where Drovix is not authorised or permitted to provide them. Instrument access, connectivity, risk parameters and commercial terms are subject to review and the signed institutional services agreement.